Dhunseri Ventures Q4 FY26: Trading Losses Eclipse Other Income Gains

May 26 2026 10:00 PM IST
share
Share Via
Dhunseri Ventures Ltd., a diversified micro-cap company with a market capitalisation of ₹876.00 crores, reported a consolidated net profit of ₹24.36 crores for Q4 FY26, marking a dramatic turnaround from the ₹10.68 crore loss in Q3 FY26. However, this quarterly recovery masks deeper operational challenges, as the company's trading business continues to bleed, with operating profit before other income plunging to negative ₹60.64 crores—the worst quarterly performance in recent history.
Dhunseri Ventures Q4 FY26: Trading Losses Eclipse Other Income Gains

The stock closed at ₹246.25 on May 26, down 0.08% from the previous session, and has declined 25.48% over the past year, significantly underperforming the broader Sensex which fell 7.50% during the same period. The market's tepid response reflects concerns about the sustainability of earnings driven primarily by treasury operations rather than core trading activities.

Consolidated Net Profit (Q4 FY26)
₹24.36 Cr
▲ 303.31% QoQ
Net Sales (Q4 FY26)
₹70.96 Cr
▼ 47.10% YoY
Operating Margin (Excl OI)
-85.46%
Deeply Negative
Other Income (Q4 FY26)
₹21.74 Cr
83.62% of PBT

The headline consolidated profit figure of ₹24.36 crores represents a substantial 303.31% sequential improvement from the previous quarter's loss of ₹6.04 crores. However, a closer examination reveals that this recovery is almost entirely attributable to treasury income and other non-operating sources, which contributed ₹21.74 crores—accounting for 83.62% of profit before tax. The standalone net loss for Q4 FY26 stood at ₹61.59 crores, highlighting the divergence between consolidated and standalone performance.

Quarter Net Sales (₹ Cr) Sales Growth (YoY) Cons. Net Profit (₹ Cr) Profit Growth (YoY) PAT Margin (%)
Mar'26 70.96 ▼ 47.10% 24.36 ▼ 127.99% 34.33%
Dec'25 71.68 ▼ 36.35% 6.04 ▼ 93.54% -0.61%
Sep'25 69.23 ▼ 53.32% -10.68 ▼ 115.76% -13.19%
Jun'25 173.48 N/A 71.26 N/A 40.82%
Mar'25 134.14 N/A -87.03 N/A -63.29%
Dec'24 112.62 N/A 93.44 N/A 66.44%
Sep'24 148.30 N/A 67.77 N/A 45.63%

Financial Performance: Revenue Collapse Exposes Trading Weakness

Dhunseri Ventures' Q4 FY26 revenue declined sharply to ₹70.96 crores, down 47.10% year-on-year and 1.00% sequentially. This marks a continuation of the revenue erosion that began in Q3 FY26, when sales plummeted 60.09% quarter-on-quarter from ₹173.48 crores in Q1 FY26. The company's trading operations in PET resin have clearly faced severe headwinds, with sales volumes and realisations both under pressure.

The operating profit picture is even more concerning. Operating profit before other income deteriorated to negative ₹60.64 crores in Q4 FY26, translating to a margin of negative 85.46%. This compares unfavourably with the negative ₹42.31 crores (margin of negative 59.03%) in Q3 FY26 and the positive ₹83.46 crores (margin of 48.11%) in Q1 FY26. The sequential decline in operating performance, despite relatively stable revenue levels, suggests mounting cost pressures and inventory losses in the trading business.

Revenue (Q4 FY26)
₹70.96 Cr
▼ 47.10% YoY | ▼ 1.00% QoQ
Consolidated Net Profit
₹24.36 Cr
▲ 303.31% QoQ | ▼ 127.99% YoY
Operating Margin (Excl OI)
-85.46%
vs -59.03% in Q3 FY26
PAT Margin
34.33%
Boosted by Other Income

Employee costs rose to ₹11.43 crores in Q4 FY26, up 39.05% from ₹8.22 crores in the previous quarter, adding to the operational strain. Interest expenses also climbed sharply to ₹14.78 crores from ₹9.76 crores quarter-on-quarter, reflecting increased borrowing costs or higher debt levels. The tax rate for the quarter stood at an unusually low 6.31%, compared to 82.80% in Q3 FY26, indicating significant tax adjustments or credits.

Critical Operating Concerns

Core Business Deterioration: Operating profit before other income has turned sharply negative at ₹60.64 crores (margin of negative 85.46%), the worst quarterly performance on record. The company's PET resin trading operations are facing severe margin compression, with losses escalating despite relatively stable revenue levels. Other income now constitutes 83.62% of profit before tax, indicating that treasury operations are masking fundamental business weakness.

Sustainability Risk: The divergence between standalone loss (₹61.59 crores) and consolidated profit (₹24.36 crores) raises questions about the sustainability of earnings, particularly if subsidiary performance weakens or treasury income normalises.

The Other Income Dependence: Treasury Operations Prop Up Results

The most striking feature of Dhunseri Ventures' Q4 FY26 results is the overwhelming dependence on other income to generate profitability. Other income of ₹21.74 crores accounted for 83.62% of profit before tax, a dangerous reliance that suggests the core trading business is fundamentally unprofitable at current operating levels. This income stream, derived primarily from treasury operations and investments, contributed ₹18.39 crores in Q3 FY26 and ₹22.49 crores in Q2 FY26, demonstrating consistency but also highlighting the lack of operational earnings power.

On an annual basis, FY25 saw other income of ₹103.00 crores against total sales of ₹480.00 crores—meaning non-operating income represented 21.46% of revenue. This ratio has been consistently elevated, with other income contributing ₹76.00 crores in FY24 and ₹76.00 crores in FY23. The company's investment portfolio stood at ₹2,375.02 crores as of March 2025, generating treasury returns that have become the primary driver of profitability.

Investment Portfolio: The Real Earnings Engine

Dhunseri Ventures' balance sheet reveals investments of ₹2,375.02 crores as of March 2025, down marginally from ₹2,509.72 crores in March 2024. These investments, which include equity holdings and other financial assets, generate the other income that has become critical to overall profitability. With shareholder funds of ₹3,189.40 crores, approximately 74.47% of equity capital is deployed in investments rather than operating assets, positioning the company more as an investment holding entity than a traditional trading business.

Balance Sheet Strength: Fortress Balance Sheet Provides Cushion

Despite operational challenges, Dhunseri Ventures maintains a robust balance sheet that provides significant financial flexibility. Shareholder funds stood at ₹3,189.40 crores as of March 2025, up from ₹2,959.20 crores in the previous year, translating to a book value per share of ₹910.40. At the current market price of ₹246.25, the stock trades at a price-to-book ratio of just 0.27x, representing a substantial discount to net asset value.

The company's debt position is modest relative to its equity base. Long-term debt stood at ₹291.80 crores as of March 2025, up slightly from ₹276.65 crores in March 2024. With cash and cash equivalents of ₹134.00 crores as of March 2025 (up from ₹26.00 crores in March 2024), Dhunseri Ventures is effectively a net cash company on an adjusted basis. The average net debt to equity ratio over recent years stands at negative 0.14, confirming the company's conservative capital structure.

However, profitability metrics remain weak. Return on equity (ROE) averaged 11.74% over recent periods but has deteriorated sharply, with the latest ROE at just 1.74%. Return on capital employed (ROCE) averaged 5.34% over the same period, with the latest reading at 7.81%—both figures well below the cost of capital and indicative of value destruction at the operating level. The average EBIT to interest coverage ratio of 7.26x provides some comfort on debt servicing capacity, though this metric is heavily influenced by other income rather than core operating earnings.

Metric FY25 FY24 FY23 FY22
Shareholder Funds (₹ Cr) 3,189.40 2,959.20 2,637.29 2,062.10
Long-Term Debt (₹ Cr) 291.80 276.65 308.80 0.00
Investments (₹ Cr) 2,375.02 2,509.72 2,306.87 1,790.01
Cash & Equivalents (₹ Cr) 134.00 26.00 60.00 27.00
Book Value per Share (₹) 910.40 844.50 752.80 588.50

Industry Leadership: How Dhunseri Ventures Compares to Peers

Within the diversified sector, Dhunseri Ventures occupies a unique position as a micro-cap investment holding company with trading operations. The peer comparison reveals both the company's valuation appeal and its operational challenges relative to larger diversified conglomerates.

Company P/E Ratio (TTM) P/BV Ratio ROE (%) Dividend Yield (%) Debt to Equity
Dhunseri Ventures NA (Loss Making) 0.27 11.74 3.47 -0.14
DCM Shriram 19.83 2.21 12.14 0.97 0.26
Swan Corp NA (Loss Making) 1.35 4.03 0.03 0.13
Sindhu Trade NA (Loss Making) 2.52 3.77 NA 0.27
Balmer Lawrie 11.30 1.51 12.03 6.95 -0.11
TTK Healthcare 17.64 1.14 19.57 1.14 -0.53

Dhunseri Ventures trades at the lowest price-to-book ratio in its peer group at 0.27x, compared to an average of approximately 1.75x for profitable peers. This deep discount reflects both the market's scepticism about the sustainability of earnings and concerns about the quality of the company's asset base. The company's ROE of 11.74% is competitive with peers like DCM Shriram (12.14%) and Balmer Lawrie (12.03%), though significantly below TTK Healthcare's 19.57%. However, the latest ROE of just 1.74% suggests recent performance has deteriorated sharply.

The dividend yield of 3.47% stands out positively, second only to Balmer Lawrie's 6.95% in the peer group. The company declared a dividend of ₹3.50 per share with an ex-dividend date of February 27, 2026, representing a payout ratio of 12.15%. This relatively low payout ratio provides room for dividend sustainability even if earnings remain under pressure, though the dividend is not well-covered by current operating cash flows.

Valuation Analysis: Deep Discount to Book Value Offers Margin of Safety

At ₹246.25, Dhunseri Ventures trades at a price-to-book ratio of 0.27x, implying the market values the company's net assets at just 27% of their stated book value of ₹910.40 per share. This represents a substantial discount that could provide downside protection for patient investors willing to bet on either a turnaround in trading operations or eventual monetisation of the investment portfolio.

The company's EV/EBITDA multiple of 2.29x and EV/Sales ratio of 0.86x appear attractive on the surface, though these metrics are distorted by the negative operating margins and heavy reliance on other income. The EV/EBIT ratio of 2.84x similarly reflects the depressed operating performance. With the company currently loss-making on a standalone basis, traditional earnings-based valuation metrics like P/E ratio are not applicable.

P/E Ratio (TTM)
NA
Loss Making
Price to Book Value
0.27x
73% Discount to NAV
Dividend Yield
3.47%
₹3.50 per share
Mojo Score
37/100
SELL Rating

The valuation grade has been classified as "Very Attractive" since October 27, 2025, reflecting the deep discount to book value. However, this attractive valuation has not translated into positive stock performance, with the share price declining 25.48% over the past year compared to a 7.50% decline in the Sensex. The 52-week trading range of ₹176.20 to ₹402.00 illustrates the high volatility, with the current price 38.74% below the 52-week high and 39.76% above the 52-week low.

Shareholding: Stable Promoter Holding, Minimal Institutional Interest

The shareholding pattern reveals a highly promoter-dominated structure with minimal institutional participation, a common characteristic of micro-cap companies. Promoter holding has remained stable at 75.00% across the last five quarters, indicating no dilution or stake sales. The promoter group is led by Dhunseri Investments Ltd. with a 65.23% stake, followed by Mint Investments Ltd. at 5.94%.

Shareholder Category Mar'26 Dec'25 Sep'25 Jun'25 QoQ Change
Promoter Holding 75.00% 75.00% 75.00% 75.00% 0.00%
FII Holding 0.57% 0.63% 0.63% 0.64% -0.06%
Mutual Fund Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Insurance Holdings 1.72% 1.72% 1.72% 1.72% 0.00%
Other DII Holdings 0.01% 0.01% 0.01% 0.01% 0.00%
Non-Institutional 22.70% 22.63% 22.64% 22.62% +0.07%

Foreign institutional investor (FII) holding declined marginally to 0.57% in March 2026 from 0.63% in December 2025, representing 23 FII entities. Mutual fund holding remains at zero, reflecting the lack of interest from mainstream institutional investors in this micro-cap name. Insurance company holdings have been stable at 1.72% across recent quarters. The total institutional holding of just 2.31% is exceptionally low and limits liquidity for larger investors.

Non-institutional investors, comprising retail and high-net-worth individuals, hold 22.70% of the equity, up marginally by 0.07% in the March 2026 quarter. Importantly, there is zero promoter pledging, which eliminates concerns about forced selling or financial distress at the promoter level. The stable shareholding pattern suggests no immediate corporate governance concerns, though the lack of institutional participation limits visibility and research coverage.

Stock Performance: Significant Underperformance Across Timeframes

Dhunseri Ventures has delivered disappointing returns across most time horizons, significantly underperforming both the broader market and its sectoral peers. The stock declined 25.48% over the past year compared to a 7.50% decline in the Sensex, resulting in negative alpha of 17.98%. The underperformance has been particularly acute in the medium term, with the stock down 29.35% over two years versus a 0.79% gain in the Sensex.

Period Stock Return Sensex Return Alpha
1 Week 5.80% 1.08% +4.72%
1 Month 3.73% -0.85% +4.58%
3 Months -2.03% -7.59% +5.56%
6 Months -16.57% -11.21% -5.36%
Year to Date -13.75% -10.81% -2.94%
1 Year -25.48% -7.50% -17.98%
2 Years -29.35% 0.79% -30.14%
3 Years 3.75% 21.61% -17.86%
5 Years 54.20% 48.99% +5.21%

Recent short-term performance has shown some resilience, with the stock gaining 5.80% over the past week and 3.73% over the past month, outperforming the Sensex in both periods. However, this bounce appears technical in nature rather than driven by fundamental improvements, as the stock remains well below its 200-day moving average of ₹287.27.

The stock's beta of 1.08 indicates higher volatility than the broader market, with annualised volatility of 39.27% compared to the Sensex's 12.99%. This high volatility, combined with negative returns, places the stock in the "high risk, low return" category—an unfavourable risk-return profile for most investors. The risk-adjusted return of negative 0.65 over the past year compares poorly with the Sensex's negative 0.58, indicating that the additional volatility has not been rewarded.

Compared to the diversified sector, which delivered a 7.84% return over the past year, Dhunseri Ventures underperformed by 33.32 percentage points. This substantial underperformance reflects both company-specific operational challenges and the market's preference for larger, more liquid diversified conglomerates with clearer earnings visibility.

Investment Thesis: Value Trap or Hidden Opportunity?

The investment case for Dhunseri Ventures presents a classic value investing dilemma: the stock trades at a substantial discount to book value (0.27x P/BV), offers a decent dividend yield (3.47%), and maintains a fortress balance sheet with net cash—yet operational performance continues to deteriorate, and the market shows no signs of recognising the apparent value.

Valuation Grade
Very Attractive
0.27x P/BV
Quality Grade
Average
Weak Operating Metrics
Financial Trend
Flat
Mixed Signals
Technical Trend
Mildly Bearish
Below Key MAs

The bull case rests primarily on asset value rather than earnings power. With investments of ₹2,375.02 crores and shareholder funds of ₹3,189.40 crores, the company's net asset value per share of ₹910.40 is 3.7 times the current market price. If the company were to liquidate its investment portfolio or unlock value through strategic restructuring, shareholders could theoretically realise significantly higher values. The dividend yield of 3.47% provides some income support whilst waiting for value realisation.

However, the bear case is equally compelling. Operating profit margins have turned deeply negative (negative 85.46% in Q4 FY26), indicating that the core trading business is destroying value at an alarming rate. The company's dependence on other income for profitability (83.62% of PBT in Q4 FY26) raises questions about the sustainability of earnings and the appropriateness of valuing the company based on book value that includes loss-making operating assets. Return on equity has collapsed to 1.74%, well below the cost of capital, suggesting that management is not effectively deploying shareholder capital.

"At 0.27 times book value, Dhunseri Ventures appears statistically cheap, but deteriorating operating margins and near-total dependence on treasury income suggest the discount may be justified—a classic value trap requiring operational turnaround before investment merit materialises."

Key Strengths & Risk Factors

✓ KEY STRENGTHS

  • Fortress Balance Sheet: Net cash position with shareholder funds of ₹3,189.40 crores and minimal debt provides significant financial flexibility
  • Deep Discount to NAV: Trading at 0.27x book value offers substantial margin of safety based on asset value
  • Strong Investment Portfolio: ₹2,375.02 crores in investments generating consistent other income provides earnings cushion
  • Attractive Dividend Yield: 3.47% yield with low payout ratio (12.15%) suggests dividend sustainability
  • Zero Promoter Pledging: Stable 75% promoter holding with no pledging eliminates governance concerns
  • Long Operating History: Company established in 1961 with experience in tea cultivation and PET resin trading

⚠ KEY CONCERNS

  • Severe Operating Losses: Operating margin of negative 85.46% in Q4 FY26 indicates core business is deeply unprofitable
  • Revenue Collapse: Sales declined 47.10% YoY to ₹70.96 crores, with no signs of stabilisation
  • Other Income Dependence: 83.62% of PBT from other income highlights lack of operational earnings power
  • Weak Return Metrics: ROE of 1.74% and ROCE of 7.81% well below cost of capital indicate value destruction
  • Minimal Institutional Interest: Just 2.31% institutional holding limits liquidity and research coverage
  • Persistent Underperformance: Stock down 25.48% over past year with negative alpha of 17.98% vs Sensex
  • High Volatility: 39.27% annualised volatility with beta of 1.08 creates unfavourable risk-return profile

Outlook: What to Watch

POSITIVE CATALYSTS

  • Turnaround in PET resin trading margins and volumes
  • Strategic restructuring or spin-off of investment portfolio
  • Improvement in operating profit margins towards breakeven
  • Increased institutional investor interest and coverage
  • Sustained treasury income supporting dividend payments

RED FLAGS

  • Further deterioration in operating margins below negative 85%
  • Continued revenue decline in coming quarters
  • Reduction in other income impacting overall profitability
  • Increase in debt levels or reduction in cash reserves
  • Dividend cut signalling financial stress
  • Promoter stake reduction or pledging of shares

The Verdict: Value Trap Requiring Operational Evidence

SELL

Score: 37/100

For Fresh Investors: Avoid initiating positions despite the attractive 0.27x price-to-book valuation. The severe operating losses (negative 85.46% margin), collapsing revenues (down 47.10% YoY), and near-total dependence on other income (83.62% of PBT) indicate fundamental business deterioration that outweighs the statistical cheapness. Wait for concrete evidence of operational stabilisation before considering entry.

For Existing Holders: Consider reducing positions on any technical bounces towards the ₹260-280 range. Whilst the fortress balance sheet provides downside protection and the 3.47% dividend yield offers some income support, the persistent underperformance (down 25.48% over one year) and lack of operational improvement suggest capital could be better deployed elsewhere. Hold only if conviction exists in long-term asset value realisation through restructuring.

Fair Value Estimate: ₹200-220 based on discounted investment portfolio value and negative operating business value (19% downside from current levels)

Rationale: The combination of deeply negative operating margins, collapsing revenues, weak return metrics (1.74% ROE), and persistent stock underperformance outweighs the attractive valuation discount. The company functions more as an investment holding vehicle than an operating business, yet the market appropriately discounts the book value given the value destruction at the operational level. A SELL rating reflects the need for tangible operational improvement before the valuation discount can be justified as an investment opportunity rather than a value trap.

Note: ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The views expressed are those of the author and do not necessarily reflect the views of the publication.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
When is the next results date for Innovision Ltd?
May 26 2026 11:22 PM IST
share
Share Via
When is the next results date for Prodocs Solutions Ltd?
May 26 2026 11:22 PM IST
share
Share Via
When is the next results date for Ravelcare Ltd?
May 26 2026 11:22 PM IST
share
Share Via
When is the next results date for Arco Leasing Ltd?
May 26 2026 11:22 PM IST
share
Share Via